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Available online 23 October 2013Abstract Definitive endoderm (DE) differentiation from mouse embryonic stem cell (mESC) monolayer cultures has been
limited by poor cell survival or low efficiency. Recently, a combination of TGFβ and Wnt activation with BMP inhibition
improved DE induction in embryoid bodies cultured in suspension. Based on these observations we developed a protocol
to efficiently induce DE cells in monolayer cultures of mESCs. We obtained a good cell yield with 54.92% DE induction as shown
by Foxa2, Sox17, Cxcr4 and E-Cadherin expression. These DE-cells could be further differentiated into posterior foregut
and pancreatic phenotypes using a culture protocol initially developed for human embryonic stem cell (hESC) differentiation.
In addition, this mESC-derived DE gave rise to hepatocyte-like cells after exposure to BMP and FGF ligands. Our data therefore
indicate a substantial improvement of monolayer DE induction from mESCs and support the concept that differentiation
conditions for mESC-derived DE are similar to those for hESCs. As mESCs are easier to maintain and manipulate in culture
compared to hESCs, and considering the shorter duration of embryonic development in the mouse, this method of efficient
DE induction on monolayer will promote the development of new differentiation protocols to obtain DE-derivatives,
like pancreatic beta-cells, for future use in cell replacement therapies.
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167Definitive endoderm monolayer from mESCIntroduction
Embryonic stem cells have a great potential in regenerative
medicine because they generate somatic cell types from all
three germ layers. For example, insulin-producing pancreatic
beta-cells derived from human embryonic stem cells (hESCs)
can be applied in type-1 diabetes. One of the problems to
overcome is that it has proven very difficult, if not impossible,
to obtain fully differentiated and functional beta-cells in vitro.
Currently, it is possible to generate pancreatic progenitors from
hESCs, and they were shown to differentiate into functional
beta-cells after a prolonged period of engraftment in mice
(Kroon et al., 2008; Mfopou et al., 2010a; Nostro et al.,
2011; Rezania et al., 2012). Further optimization is needed
to establish suitable conditions required for beta-cell
differentiation in vitro. To this end, the study of mouse
embryonic stem cells (mESCs) can be useful for several
reasons. First, in vitro differentiation protocols are intended
to mimic the conditions in the developing embryo and
most knowledge on embryonic development of the pancreas
was accumulated from mouse studies. Furthermore, the
timeline for the specification and maturation of a particular
cell is theoretically shorter in mice than humans (respectively
3 weeks and 40 weeks). Second, mESCs are easier to maintain
in culture as they grow faster, aremore resistant to enzymatic
dissociation during passaging, and have less tendency to
spontaneously differentiate. mESCs can thus be used as a
model to rapidly tweak protocols that thereafter could be
implemented on hESCs, for example to obtain beta-cells.
However, despite the similarities in their general properties,
embryonic stem cells from mouse and human differ in their
manipulation in vitro, which is related to the developmental
origin of these cells. Indeed, in contrast to mESCs, pluripotent
cells derived frommouse epiblast stage embryos (epiblast stem
cells, EpiSCs) can be considered as the true developmental
counterparts of hESCs. Interestingly, both EpiSCs and hESCs
were shown to require the same culture conditions (Brons
et al., 2007; Tesar et al., 2007). Human and mouse ESCs also
differ in the conditions needed for definitive endoderm (DE)
induction, the first step towards commitment into pancreatic
and other gastrointestinal fates (Mfopou et al., 2010b).
Whereas hESCs cultured as monolayers and stimulated with
Activin A and Wnt3a in a basic medium efficiently generate DE
progenitors, mESCs cultured under similar conditions usually
fail to survive or they generate DE cells with low efficiency
(b25%) (D'Amour et al., 2005; Hansson et al., 2009; Morrison et
al., 2008; Sulzbacher et al., 2009; Tada et al., 2005; Yasunaga
et al., 2005). On the contrary, mESCs cultured as embryoid
bodies generate DE cells in the presence of ActA with an
efficiency that can reach 85% if Noggin is also supplemented
(Gadue et al., 2006; Kubo et al., 2004; Li et al., 2011). We
have previously shown that embryoid bodies do not constitute
an optimal environment for efficient differentiation into
pancreatic phenotypes (Mfopou et al., 2005, 2007). Interestingly,
monolayer cultures are also technically more practical and
simple to rapidly analyze microscopically; e.g. they don't need
to be embedded and sectioned. They are thus optimal for high
throughput screening of growth factor and small molecule
combinations.
DE cells were recently generated from mouse embryoid
bodies using a combination of ActA (TGFβ activator), Noggin
(BMP antagonist), and lithium chloride (Wnt pathway activator)(Li et al., 2011). Whereas ActA and Wnt activators are
commonly used for DE induction, Noggin supplementation is
justified by the requirement for low BMP signaling to direct the
mesendoderm towards anterior primitive streak derivatives
(D'Amour et al., 2005; Sumi et al., 2008; Wang et al., 2012).
In the present study, we implemented this protocol in mESC
monolayer cultures using different GSK3β inhibitors to activate
the Wnt pathway. We show an efficient DE-derivation from
these cultures and the generation of Pdx1 + Nkx6.1+
pancreatic progenitors following the strategies that we
previously developed with hESCs (Mfopou et al., 2010a; Sui
et al., 2012). Furthermore, we present data indicating that
the mESC-derived DE cells also give rise to hepatocyte-like
cells. Therefore, these findings constitute an optimal and
rapid model for further screening growth factor and small
molecule combinations in view of the differentiation of
endoderm progenies such as the pancreatic beta cells.
Materials and methods
Cell culture and differentiation
Mouse ESCs were maintained undifferentiated on inactivated
mouse embryonic fibroblasts (feeders) in knockout DMEM (Life
Technologies, Paisley, UK) supplemented with 15% knockout
serum replacement (KOSR; Life Technologies), 1× non-essential
amino-acid (Sigma, Saint-Louis, USA), 1× Glutamax (Life
Technologies), 1× Penicillin–Streptomycin solution (Sigma),
0.55 mM beta-mercaptoethanol (Life Technologies) and
1000 U/ml leukemia inhibitory factor (LIF; Sigma). Cells were
passaged on new feeder layers every 3 days by dissociation with
recombinant trypsin (TrypZean; Sigma). For differentiation
studies, dissociated mESCs (about 105 cells/cm2) were seeded
with the carry-over feeders on gelatin-coated plates. Initially,
definitive endoderm was induced in RMPI or DMEM (Life
Technologies) two days after seeding mESCs and using ActA
(10 to 50 ng/ml; RnD Systems, Minneapolis, USA), Wnt3a
(25 ng/ml; RnD Systems), FGF2 (10 ng/ml; Life Technologies),
EGF (50 ng/ml; Sigma), BMP4 (10 ng/ml; RnD Systems),
LY294002 (10 μM; Sigma), FBS (0.2 to 5%; PAA, Pasching,
Austria), KOSR (2 to 5%; Life Technologies) and B27
supplement (1%, Life Technologies). Later on, DE was induced
with a combination of ActA (50 ng/ml), Noggin (200 ng/ml;
RnD Systems) and a GSK3β inhibitor (1 μM of 6-bromo
indirubin-3-oxine (BIO; Merck KGaA, Darmstadt, Germany);
2.5 μM of 1-azakenpaullone (AKP; Sigma) or 5 μM of CHIR99021
(CHIR; Stemgent, San Diego, USA) (Li et al., 2011)). The GSK3β
inhibitor was supplemented for 2 days (2+ and 2 + 2−) or for
the entire 4 days (4+) and the chemically defined medium
(CDM) usedwasmade of 50% DMEM, 50% DMEM-F12, 0.2% bovine
serum albumin (Life Technologies), 2 mM Glutamax, 0.5 mM
ascorbic acid (Sigma) and 0.55 mM beta-mercaptoethanol.
An overview of the conditions tested is given in Supplementary
Table 1.
For the differentiation towards pancreatic lineages (Mfopou
et al., 2010a; Nostro et al., 2011; Sui et al., 2012, 2013), DE
cells (stage 1) were cultured in DMEM + 1% B27 and exposed to
Noggin (100 ng/ml; RnD Systems), KAAD-cyclopamine (250 nM;
Merck KGaA), retinoic acid (2 μM, Sigma) and FGF10 (25 ng/ml;
RnD Systems) for 6 to 8 days, then to FGF10 (50 ng/ml) for
4 days (stage 2) and finally to Noggin (100 ng/ml) and the Notch
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(stage 3).
To induce differentiation towards the hepatic lineage,
DE cells were cultured in the presence of 20 ng/ml BMP4,
10 ng/ml FGF2 and 50 ng/ml FGF10 (all from RnD Systems)
for 5 days (stage 2L), and finally exposed to 10 ng/ml
Oncostatin M, 10 ng/ml HGF and 25 ng/ml FGF10 (all from
RnD Systems) for another 5 days (stage 3L).
RT-PCR analysis
Total RNA was extracted at 3 time points during DE induction
(days 2, 4 and 6) and at 2 time points during pancreatic
or liver differentiation using the GenElute mammalian total
RNA extraction kit (Sigma). RNA concentration and quality
were assessed on the Nanodrop-1000 spectrophotometer
(Nanodrop, Wilmington, USA). Reverse transcription was
carried out from 500 ng total RNA using GoScript RT system
(Promega, Fitchburg, Wisconsin) and the cDNA was amplified
with the GoTaq qPCR assay (Promega) or the Express
SybrGreener kit (Life Technologies) on a fast thermal cycler
(ABI 7900HT; Life Technologies). The complete list of targets
and primers is available in the Supplementary Table 2.
Amplification data were analyzed following the dCt method
and reported as a percentage of the housekeeping gene
(Gapdh) level in the same samples.
Immunofluorescence analysis
Cells were fixed in 4% formaldehyde for 15 min at room
temperature and permeabilized when necessary with cold
methanol for 20 min. They were exposed to 2% donkey
serum to block non-specific binding and incubated overnight
with the primary antibodies at 4 °C. Cells were washed
thrice in phosphate buffered saline (PBS) between these steps.
The primary antibodies used were against Albumin (1/200,
A6684; Sigma), Amylase (1/500, A8273; Sigma), Cxcr4 (1/100,
MAB171; RnD Systems or 1/100, 12-9991; eBioscience,
San Diego, USA), E-Cadherin (1/50, 610182; BD Biosciences,
Franklin Lakes, NJ, USA), Foxa2 (1/200, SC9187; Santa Cruz
Biotechnology, Santa Cruz, USA), Glucagon (1/1000; Sigma),
Gsc (1/100; Santa Cruz Biotechnology), Hnf1b (1/100; Santa
Cruz Biotechnology), Ngn3 (1/200, AF3444; RnD Systems),
Nkx6.1 (1/500, F55A10; Developmental Studies Hybridoma
Bank, Iowa, USA), Pdx1 (1/200, AF2419; RnD Systems), Sox9
(1/250, AB5535; Merck Millipore, Billerica, USA), Sox17 (1/100,
MAB1924; RnD Systems), Synaptophysin (1/100, AP15805PU-N;
Acris Antibodies, Herford, Germany), and T (1/100, AF2085;
RnD Systems). Control stainings were performed with isotype
immunoglobulins from mouse, rabbit or goat wherever
indicated (Supplementary Fig. 1c). The secondary antibodies
used were FITC-, Cy2-, TRITC- or Cy3-labeled donkey anti-goat,
donkey anti-mouse, donkey anti-rabbit, and donkey anti-sheep;
all obtained from Jackson ImmunoResearch Laboratories, West
Grove, USA. Nuclei were stained with DAPI (5 μg/ml; 4,6′-
diamidino-2-phenylindole; Thermo Scientific, Rockford, IL,
USA) and analysis was performed using the Eclipse TE2000
fluorescence microscope (Nikon, Tokyo, Japan) or the multi-
photon laser-scanning microscope (LSM710 and ConfoCor 3
system; Zeiss, Oberkochen, Germany). Pictures were acquired
from at least 8 fields per sample, using the same microscopeand camera settings in each experiment. The proportion
of positive cells was indirectly estimated by measuring the
area above threshold for a given marker, and presenting it as
percentage of total DAPI-positive area. Measurements were
performed using the object count function of the NIS Elements
AR 3.22 software (Nikon, Tokyo, Japan). The percentage of
cells co-expressing Foxa2 and Sox17 or E-Cadherin and Cxcr4
was also determined using the same technique, but on samples
double-stained for both markers.
Flow cytometry
Expression of the surfacemarker Cxcr4 during DE differentiation
was further analyzed by flow cytometry. For this purpose,
mESCs or differentiated cells at day 2 and day 6 were rinsed in
PBS, dissociated with Accutase (5 min; Life Technologies) and
washed in ice-cold FACS buffer (2% FBS in PBS). Cells were
exposed for 45 min to the phycoerythrin-labeled rat anti-Cxcr4
(1/500, 12-9991; eBioscience) or to the corresponding rat IgG2b
isotype control (1/500, 12-4031; eBioscience). Cells were then
washed twice in FACS buffer and analyzed on a BD FACSAria
system (100,000 events per sample; BD Biosciences). The
percentage of Cxcr4+ cells in each sample was determined
after correction for the corresponding background fluorescence
recorded with the isotype control.
Transplantation
Cells differentiated towards the pancreatic lineage were
dissociated at stage 3 into small clusters, seeded onto a
collagen sponge (Gelfoam; Pharmacia and Upjohn, Michigan,
USA) and overlaid with 50% Matrigel (BD Biosciences). The
grafts, which contained approximately 2 million cells, were
then implanted under the dorsal subcutaneous space of sixmale
NOD-SCIDmice aged 10–12 weeks. These experiments followed
the recommendations of the Belgian Regulations for Animal
Care and were approved by the local Ethical Committee for
Animal Experimentation.
Statistical analysis
All in vitro experiments were performed at least 3 times
independently and results are displayed as mean with SD.
Data were analyzed using the non-parametric tests: Mann
Whitney test for two samples and Kruskal–Wallis test with
Dunn's multiple comparisons for several samples (one-way
ANOVA; Prism 5; GraphPad Software, La Jolla, USA). The
statistical significance levels of several tests are shown
in Supplementary Tables 3–4.
Results
Current DE induction methods from mESCs on
monolayer are inefficient
The implication of Nodal and Wnt signals in vertebrate DE
differentiation is well described. ActA and Wnt3a respectively
activate these pathways and are used as standards for DE
induction from embryonic stem cells (D'Amour et al., 2005).
However, this method is not optimal for mESC monolayer
Figure 1 Combining ActA, BIO and NG efficiently generated DE onmonolayer frommESCs. a) Induction ofmesendoderm and DEmarker
expression on day 2, day 4 (2+), and day 6 (2 + 2− and 4+) following exposure to ActA, BIO and NG. Statistical significance is versus mESCs
(a) or CDM day 2 (b). b) Detection of T protein expression in 30 to 50% cells on day 4 and on day 6. Note the absence of T protein before
treatment (CDM day 2). c) Detection of Foxa2 and Sox17 co-expression in differentiated cells as from day 4. (CDM day 2, cells cultured for
2 days in the differentiation mediumwithout inducing factors; (2+), two day treatment with ActA–BIO–NG; (2 + 2−), four day treatment
but without BIO during the last two days; (4+), four day continuous treatment with ActA–BIO–NG). Scale bars are 100 μm in b) and c).
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of the reported models (Hansson et al., 2009; Morrison et al.,
2008; Tada et al., 2005; Wang et al., 2012; Yasunaga et al.,
2005). We also observed N90% cell loss on day 4 following
the exposure of mESCs to 50 ng/ml ActA and 25 ng/ml Wnt3a
for 2 days, then to ActA and 0.2% FBS in RPMI medium. Despite
the occurrence of small clusters of cells expressing Sox17
and Foxa2, the overall profile of DE marker expression wascomparable to that in control mESCs treated with 5% FBS for
4 days (Supplementary Fig. 1), and the low cell yield limited
further differentiation and analysis. We also obtained similar
data upon treatment with ActA alone at concentrations of 10,
25 or 50 ng/ml (data not shown). Therefore, in agreement
with the literature (Morrison et al., 2008), current methods
for DE induction from mESCs on monolayer are not efficient
enough.
Figure 2 Wnt pathway activation during DE induction by the small molecules AKP and CHIR. a) Induction of mesendoderm and DE
marker expression on day 6 following exposure to indicated conditions. Statistical significance is versus mESCs (a) or ActA-BIO-NG (b).
b) Detection of Foxa2 and Sox17 co-expression in about 75% differentiated cells on day 6 (DE stage) using either AKP or CHIR.
c) Detection of Gsc expression on day 6 in DE cells generated with ActA–AKP–NG. d) Detection of Cxcr4 expression on day 6 in DE cells
following exposure to ActA–CHIR–NG. Scale bars are 100 μm in b) and c); 50 μm in d).
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components (FBS, KOSR, FGF2, BMP4, EGF, B27 supplement)
or by modulating the initial cell density. In several conditionsFigure 3 Assessment of the proportions of positive cells. a) Percen
after differentiation with ActA–AKP–NG or ActA–CHIR–NG. Data co
Cxcr4 performed with mESC, DE-induced cells on day 2 (CDM, day 2) a
cells treated with 5% FBS for 6 days. c, d, e) Immunofluorescence an
nearly all E-Cadherin+ cells (54% of total cells or 73% of Cxcr4+ cells)
(26%) are negative for E-Cadherin (c) and might represent mesode
for the pancreas progenitor markers Pdx1 and Nkx6.1 at stages 2 and
Scale bars are 50 μm.tested, a monolayer was obtained but the characteristic DE cell
morphology was observed only in FBS- and EGF-treated cultures
(Supplementary Fig. 2). Addition of LY294002 to block the PI3Ktage of DAPI+ area that also stained for the indicated DE markers
llected at the DE stage. b) FACS analysis for the surface marker
nd on day 6 (ActA-CHIR-NG, displayed on FACS plots) and control
alysis for E-Cadherin and Cxcr4 expression in DE cells. Note that
are Cxcr4+ (d) and represent DE cells, and that few Cxcr4+ cells
rm or mesendoderm. f) Percentage of DAPI+ area that stained
3 following DE induction with ActA–AKP–NG or ActA–CHIR–NG.
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172 J.K. Mfopou et al.pathway (McLean et al., 2007) abrogated the beneficial effects
of FBS, KOSR or FGF2. Several of the tested supplements
increased T, Gsc and Cxcr4, but not Sox17 and Foxa2
expression; and this effect was not significant when compared
to ActA+Wnt3a method. Treatment with BMP4 led to
the highest T induction (Supplementary Fig. 3a). Immuno-
fluorescence analysis detected T+ cells and Foxa2+ cells
that were devoid of Sox17 signal (Supplementary Fig. 3b, c and
data not shown). Together, these data suggest that the added
components improved cell yield, but they also restrained
further endoderm differentiation from mesendoderm cells.
ActA, BIO and NG combination efficiently generates
DE from mESC monolayer cultures
Recently, Li et al. combined the TGFβ agonist ActA, the Wnt
pathway activator lithium chloride (LiCl) and the BMP inhibitor
Noggin (NG) to induce DE in embryoid bodies from mESCs
cultured in suspension. An efficiency of 80–85% was achieved,
which is a major improvement compared to earlier reports
(Kubo et al., 2004; Li et al., 2011; Morrison et al., 2008).
We aimed at implementing this protocol in mESC adherent
culture, but making use of the small molecule BIO instead of
LiCl to activate the Wnt pathway. This treatment resulted in
the differentiation of epithelial like cells with typical DE
morphology (Supplementary Fig. 4a) as from day 4. These
monolayers further increased in size, covering at least 50% of
the culture surface by day 6. After only 2 day exposure (2+) of
mESCs to this combination, T expression was significantly
induced, about 10-fold higher than at the mesendoderm stage
of the ActA+Wnt protocol and remained high till day 6 without
(2 + 2−) or with (4+) BIO supplementation (Fig. 1a and data not
shown). T protein was detected in 30 to 50% of differentiated
cells at days 4 and 6, while virtually none was found before
treatment (CDM day 2; Fig. 1b).
We then analyzed the expression of a panel of DE markers
(Gsc, Sox17, Foxa2 and Cxcr4) in this model. They all showed a
significant increase as from day 4 (2+), and the levels of T,
Sox17, Foxa2 and Cxcr4 further increased on day 6, though not
significantly, following continuous Wnt pathway activation
((4+) vs (2 + 2−); Fig. 1a). In line with these data, immuno-
fluorescence indicated that about 75% cells onmonolayers were
Foxa2 and Sox17 double positive at day 6 (DE stage), whereas
such cells were not found at day 2. Foxa2 + Sox17+ cells were
also present at day 4 onmonolayers of smaller size compared to
day 6 (Fig. 1c, Supplementary Table 3). We also detected Cxcr4
staining on the surface of DE cells at day 6, but not at
intermediate stages (Supplementary Fig. 4c). Taken together,
these findings indicate that the combination of a TGFβ agonist,
a Wnt pathway activator and a BMP inhibitor significantly
improves cell yield and efficiently generates DE from mESC
adherent culture, confirming previous report in EBs model (Li
et al., 2011).
Wnt pathway activation during DE induction by the
small molecules AKP and CHIR
In view of the positive outcome of our experiments
performed with a different Wnt pathway activator than in
the original protocol (BIO versus LiCl; (Li et al., 2011)), we
aimed at evaluating two other small molecules AKP andCHIR, which are more specific for GSK3β inhibition in the
micromolar range. Adherent cultures of mESCs were exposed
to AKP or CHIR in combination with ActA and NG for 4 days
and the data were compared to those obtained when using
BIO or Wnt3a. These combinations defined four conditions
here referred to as ActA–AKP–NG, ActA–BIO–NG, ActA–
CHIR–NG and ActA–Wnt–FBS. Similar to the findings with
BIO, treatments using AKP and CHIR resulted in large
monolayers of epithelial cells with typical DE morphology
(Supplementary Fig. 4b). Several DE markers (except Gsc)
were significantly induced following exposure to ActA–
AKP–NG or to ActA–CHIR–NG for 4 days, and their levels
were usually comparable to those in ActA–BIO–NG (Fig. 2a).
Of note, these treatments did not significantly induce the
expression of Meox1, Sox1 and Sox7, which are the markers
of mesoderm, ectoderm, and visceral endoderm respectively
(Supplementary Fig. 5a and data not shown).
Using immunofluorescence analysis, we detected the
co-expression of the DE markers Foxa2 and Sox17 in 74%
differentiated cells (Figs. 2b, 3a, Supplementary Table 3).
Moreover, 43 to 47% were also positive for the primitive
gut tube marker Hnf1b (Fig. 3a, Supplementary Fig. 4d). The
two other DE markers Gsc and Cxcr4 were also detectable in
both ActA–AKP–NG and ActA–CHIR–NG (Figs. 2c, d, 3a and
data not shown). Using fluorescence-activated cell sorting
(FACS) analysis, we found that an average of 73.32 ±
10.71% DE cells were positive for the surface marker
Cxcr4. This percentage was significantly higher compared
to the proportions before induction (mESCs, CDM day 2), or
after differentiation in FBS (Fig. 3b). We finally assessed
E-Cadherin and Cxcr4 co-expression by immunofluorescence,
which allows segregating DE cells (E-Cadherin + Cxcr4+),
mesoderm cells (E-Cadherin−Cxcr4+) and visceral endoderm
(E-Cadherin + Cxcr4−). Whereas 26.04% Cxcr4+ cells were
devoid of E-Cadherin expression, virtually all E-Cadherin+ cells
also expressed Cxcr4. This indicates that the efficiency of DE
induction is 54.92 ± 15.73% in our model (Fig. 3c, d, e).
BMP inhibition was critical for the increased cell yield,
considering that treatment with ActA and GSK3β inhibitors
still resulted in major cell loss. To further examine its role
in this model, we treated adherent mESCs with
ActA+EGF+B27 for 4 days to generate Foxa2 + Sox17−
mesendoderm-like cells, then we exposed them to ActA+NG
for 2 other days. Interestingly, many cells turned on Sox17
expression, indicating a progression towards the DE phenotype
(Supplementary Fig. 5b). Considering all these findings, we
conclude that DE is efficiently generated from adherent mESC
cultures irrespective of the small molecule used for Wnt
pathway activation, and that BMP inhibition is crucial in this
process.Induction of pancreatic progenitors from
mESC-derived DE cells
In our previous studies, we designed a protocol for the
differentiation of pancreatic progenitors from hESCs on
adherent cultures, and showed that these PDX1+ cells further
generated PDX1 and NKX6.1 double positive cells as well as
NGN3 positive endocrine progenitors after transplantation in
mice (Mfopou et al., 2010a; Sui et al., 2013). Here, we sought
whether this protocol with minor modifications could induce
Figure 4 RT-PCR analysis of pancreas markers in progenies of mESCs initially induced with ActA–AKP–NG (black bars) or ActA–
CHIR–NG (gray bars). Note that the pancreatic markers Pdx1, Nkx6.1 and Ptf1a are significantly induced as from stage 2, whereas the
DE and primitive gut tube markers Foxa2 and Hnf1b are already induced at stage 1. The endocrine marker Ngn3 is just marginally
affected, while hormones (Ins1, Ins2, Gcg) are mainly expressed at stage 3. Statistical significance is versus mESCs (a) or stage 1 (b).
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cells.
We first analyzed pancreatic gene expression in progenies
obtained after DE induction by ActA–BIO–NG. In contrary to
Foxa2 and Sox9 that were induced at stage 1 and maintained
thereafter, the pancreas progenitor markers Pdx1 and
Nkx6.1 were significantly increased from stage 2. There
was no significant change in Ptf1a expression, while Ins1
and Gcg were significantly induced at stages 2 and 3 despite
the much lower levels of Ngn3 expression (Supplementary
Fig. 6a). Immunofluorescence analysis identified Pdx1+
cells at stages 2 and 3, and Nkx6.1+ cells at stage 3 only,
suggesting a progressive differentiation from stage 2 to 3.
Co-expression of Pdx1 and Nkx6.1 was limited to about 30% of
the Pdx1+ cells (Supplementary Fig. 6b and data not shown).
Persistent expression of Foxa2 was also confirmed at stage 3,
whereas only low Albumin signal was detected in these
cultures (Supplementary Fig. 6c) (Mfopou et al., 2010a).
We also examined the differentiation of pancreas
progenitors following DE induction with ActA–AKP–NG
or ActA–CHIR–NG. As mentioned above, Foxa2 and Hnf1btranscripts were significantly induced at stage 1 and persisted
until stage 3 in both conditions. Pdx1 and Nkx6.1 expression
increased from stage 2, associated with a moderate but
significant induction of Ptf1a and downregulation of the DE
markers Gsc and Cxcr4 (Fig. 4, Supplementary Fig. 6d).
Once again, Ngn3 expression was not influenced by these
culture conditions, while transcripts of the pancreas hormones
Ins1, Ins2 and Gcg showed significant induction at stage 3
(Fig. 4). We also confirmed by immunofluorescence analysis
that Pdx1 + Nkx6.1− cells were frequently detected at stage
2, whereas Pdx1 + Nkx6.1+ cells were almost exclusively
found in small aggregates or on monolayer at stage 3 (Figs. 3f,
5ab). The proportions of Pdx1+ and Pdx1 + Nkx6.1+ cells were
similar irrespective of the GSK3β inhibitor used during DE
induction, and they all significantly increased between stages
2 and 3 (Figs. 3f, 5a, b; Supplementary Figs. 6b, 7). We used
confocal microscopy to ascertain the expression of these two
markers in the same cell (Supplementary Fig. 7). Despite
several attempts to demonstrate beta-cell differentiation, we
failed to unambiguously detect Insulin at stage 3 or after
additional culture for one week. However, few Ngn3+ cells and
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frequently identified (Fig. 5c, d). Together, these data
indicate the potential of mESC-derived DE cells to generate
Pdx1 + Nkx6.1+ pancreatic and endocrine progenitors in vitro.
Differentiation of mESC-derived DE towards the
hepatic lineageWe finally assessed the differentiation potential towards
the hepatic lineage. Whereas only low Albumin signal could
be detected upon differentiation towards the pancreatic
phenotype (Supplementary Fig. 6c), initial exposure of DE
cells to BMP and FGF ligands followed by treatment with
Oncostatin M, HGF and FGF10 generated large clusters of
Albumin+ cells. Most of these expressed Foxa2 at a lower level
than the neighboring Albumin− cells, and only very few Pdx1+Figure 5 Expression of pancreatic markers in progenies of mESCs in
2, the Pdx1+ cells (17.75 to 43.50%) were devoid of Nkx6.1 signal. b)
to 57.01%) and the Pdx1 + Nkx6.1+ cells accounted for 39.55 to 50.9
stage 3, most of which were negative for Foxa2. d) Only very few Ngn
were frequent at stage 3. Scale bars are 150 μm in a–b), and 100 μor Nkx6.1+ cells were found in these cultures (Supplementary
Fig. 8a and data not shown). Transcript analysis revealed a
significant induction of Foxa2, Hnf1a, Hnf6 and Albumin at
stage 3L, while expression of Alpha-fetoprotein was marginally
and transiently induced (Supplementary Fig. 8b). Furthermore,
the pancreatic marker Pdx1 remained at basal levels as well as
the cytochrome gene Cyp3a11 that marks mature hepatocytes
(Supplementary Fig. 8c). Altogether, these findings indicate
the differentiation of DE cells into a fetal hepatocyte-like
phenotype.Identification and isolation of lineage progenitors
are required before transplantation
Several recent reports have documented the further
differentiation and maturation of hESC-derived pancreaticitially induced with ActA–AKP–NG or ActA–CHIR–NG. a) At stage
At stage 3, the proportion of Pdx1+ cells further increased (29.25
9% of the Pdx1 + cells. c) Glucagon+ cells were also identified at
3+ cells were detected, whereas clusters of Synaptophysin+ cells
m in c–d).
175Definitive endoderm monolayer from mESCprogenitors after transplantation in mice (Eshpeter et al.,
2008; Kroon et al., 2008; Rezania et al., 2012; Sui et al.,
2013). Such data are not yet available using progenies of
mESCs. We assessed whether pancreatic progenitors derived
by our methods could further differentiate after subcutaneous
implantation in NOD-SCID mice. These experiments could
not be conducted to term because teratoma developed about
5 weeks after graft implantation in all six mice included.
Interestingly, histological analysis of these tumors revealed a
higher representation of endoderm-like phenotypes (intestine,
lung, ductal and glandular structures) and a much lower
occurrence of mesoderm and ectoderm derivatives such
as cartilage and neural epithelium (Supplementary Fig. 9a).
Immunofluorescence analysis identified foci of cells expressing
Pdx1, Nkx6.1, Foxa2, Sox9 and Amylase (Supplementary Fig. 9b)
but no pancreatic endocrine markers were detected. These
findings urge for the purification of pancreatic progenitors
from immature or undifferentiated cells before using them for
transplantation in vivo.Discussion and conclusion
In these studies, we primarily addressed the low efficiency of
DE differentiation from mESCs when performed on adherent
cultures. It was already known from hESC cultures that
exposure to ActA and Wnt3a for DE induction is associated
with a high degree of cell death during the first two days,
however this phenomenon is more pronounced in mESCs
where more than 90% cell death can be observed (Mfopou
et al., 2010a; Morrison et al., 2008). This explains the
preference given to the embryoid body formation prior to DE
induction from mESCs or the use of low ActA concentration
(Sulzbacher et al., 2009; Tada et al., 2005; Yasunaga et al.,
2005). The drawbacks of these two alternatives are the
stochastic differentiation within EBs, which is limitative for
achieving high efficiency as on monolayer (D'Amour et al.,
2005; Kubo et al., 2004), and the concomitant mesoderm
induction at low ActA concentrations. Conversely, the high
degree of cell loss on monolayers precludes further study of
endoderm differentiation in vitro. Considering the similarities
between several developmental features in mouse and
human, the easier manipulation of mESC cultures should
constitute an advantage for its use as a rapid screening model
to identify new combinations of growth factors and small
molecules to be further tested or implemented in hESC
differentiation, for instance towards the beta-cells. Because
the developmental counterparts of hESCs are mouse EpiSCs
but not mESCs, and given their very recent discovery, it will
be interesting in the future to evaluate their use as a
screening model instead. Nevertheless, it is expected that
DE generated from EpiSCs would be quite similar to those
obtained from mESCs differentiation.
Our findings that FGF2, BMP4 or EGF improved cell yield
but in a context of increased T and reduced Sox17 expression
suggest the mesendoderm phenotype of differentiated
cells. When further exposed to the BMP inhibitor Noggin,
they progressed towards Foxa2 + Sox17+ DE-like cells, which
is concordant with the findings that mesendoderm pro-
genitors induced by activating the Wnt pathway require
Noggin treatment in order to differentiate into anterior
endoderm with features that are much similar to nativeE8.25 definitive endoderm (Sumi et al., 2008; Wang et al.,
2012). This beneficial effect of Noggin prompted us to
examine its combination with ActA and a GSK3β inhibitor
(Li et al., 2011) on monolayer cultures of mESCs. Interestingly,
this resulted in large epithelial sheaths withmorphological and
molecular characteristics of DE cells. Therefore, activation
of TGFβ and Wnt pathways should be combined with BMP
antagonism to efficiently generate DE from mESC adherent
cultures. These findings therefore represent a significant
progress versus the initial protocol with ActA+Wnt3a.
Considering the shorter timeline of mouse development,
we assume that this study offers a rapid screening model
for improving differentiation towards desired cell types.
Whereas continuous exposure to all three factors (4+)
resulted in higher levels of DE genes, there was no significant
difference in the proportion of Foxa2 + Sox17+ cells when
compared to transient Wnt activation (2 + 2−). Surprisingly, T
expression in a fraction of differentiated cells was detected in
both conditions. We assume that this represents residual T
protein expressed at the mesendoderm stage (Bakre et al.,
2007; Tada et al., 2005). The efficient DE differentiation that
we observed is concordant with the findings in EBs treated
similarly (80% Cxcr4+ cells), and is further strengthened by the
co-labeling with E-Cadherin that excludes Cxcr4-expressing
mesoderm cells or visceral endoderm (Li et al., 2011; Morrison
et al., 2008; Yasunaga et al., 2005). Furthermore, this method
allows for a robust and FACS-detectable expression of the
surface marker Cxcr4 at the DE stage, and not 4 days later as
recently suggested (Naujok and Lenzen, 2012). The profile
of Cxcr4 also suggests that it marks the established DE cells
and is not required early during their differentiation. It will
therefore be possible in the future to purify Cxcr4+ cells
exactly at the DE stage and use them for further analysis or
differentiation, which will thereby exclude extraembryonic
endoderm cells that are actually not expected when the Wnt
pathway is so highly activated (Chazaud and Rossant, 2006).
We examined the pancreatic differentiation potential of
mESC-derived DE cells, following a strategy that we previously
applied to hESC cultures (D'Amour et al., 2006; Mfopou et al.,
2010a; Nostro et al., 2011; Sui et al., 2012). This resulted in
the differentiation of Pdx1+ and Pdx1 + Nkx6.1+ cells that can
be considered as posterior foregut and pancreatic progenitors
respectively. Expression of Nkx6.1 protein followed that of
Pdx1, indicating a progressive differentiation as occurs in vivo
(reviewed in (Gittes, 2009; Oliver-Krasinski and Stoffers, 2008)).
Our findings further support the view that the main pathways
regulating pancreas development are conserved between
mouse and human, and therefore validate this model as
a screening tool. To this end, the easy manipulation of mESCs
in culture represents an asset for the optimization of
differentiation protocols that aim at generating functional
cells in vitro. Of course, implementation of such protocols
back to hESCs might still need some adjustments.
Failure to demonstrate beta cell differentiation (Insulin+
or C-peptide+ cells) from our cultures is in line with the
current status of ESC research, and suggests that Glucagon+
and Synaptophysin+ cells that we detected are endocrine
cells of the primary transition as described during pancreas
development and during hESC differentiation (D'Amour et
al., 2006; Oliver-Krasinski and Stoffers, 2008; Van Hoof et
al., 2009). This situation has prompted the evaluation of
Pdx1 + Nkx6.1+ progenitors in diabetes cell therapy, assuming
176 J.K. Mfopou et al.that the in vivo microenvironment will guide the generation
of functional beta-cells after transplantation (Eshpeter et al.,
2008; Kroon et al., 2008; Rezania et al., 2012; Schulz et al.,
2012; Sui et al., 2013; Tuch et al., 2011). In the experiment
that we performed with crude cell cultures containing about
25% Pdx1 + Nkx6.1+ cells, all transplanted animals developed
teratoma in which tissues of endodermal origin were more
frequent. This proportion is far higher than the 13 to 46%
tumor rates reported with implanted hESC-derived pancreas
progenitor cell preparations (Kelly et al., 2011; Kroon et al.,
2008; Sui et al., 2013). Therefore pancreatic progenitors
should be sorted out before their implantation in vivo.
Considering that CD24 does not specifically label the Pdx1+
progenitor cells derived frommouse and human ESC as initially
suggested, more attention should be paid to CD142 and
to the discovery of new surface markers (Jiang et al., 2011;
Kelly et al., 2011; Naujok and Lenzen, 2012).
We also showed that the generated DE cells engage into
hepatic differentiation when treated with BMP and FGF ligands.
In this setting, the pancreatic markers were not induced,
indicating a dependence of the DE cells on the signaling
molecules applied. Despite the abundant expression of
Albumin and Foxa2, the differentiated hepatocyte-like cells
were not mature yet, as they showed no significant induction
of Cyp3a11.
In conclusion, our study reveals a new method producing
high yields of DE cells on monolayers from mESCs, and
demonstrates the relevance and potentially universal
nature of the current protocol for pancreatic progenitor
differentiation from vertebrate definitive endoderm. The
DE cells obtained by this method also generated fetal
hepatocyte-like cells in vitro. This model can be used as a
rapid and easy in vitro screening tool to optimize conditions
for generating differentiated and functional cells, such as
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